Find research datasets worth reusing

openGEO-OpenJun 2019View details →

Systematic evaluation of RNA-Seq preparation protocol performance (RNASeq: SMARTer)

GEO Series GSE131396. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJun 2019View details →

Systematic evaluation of RNA-Seq preparation protocol performance (RNASeq: TruSeq)

GEO Series GSE131397. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2021View details →

Evaluating Capture Sequence Performance for Single-cell CRISPR-activation Experiments

GEO Series GSE164393. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJan 2022View details →

To perform a standard RNAseq experiment to evaluate the impact of the knockout of Zeus gene(CG9573) in D. melanogaster

GEO Series GSE192879. Drosophila melanogaster. 6 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenAug 2023View details →

Thinking out of the box to evaluate the performance of engineered SOX17 in pluripotency reprogramming (RNA-Seq)

GEO Series GSE205192. Mus; Mus musculus. 21 samples. Type: Expression profiling by high throughput sequencing.

opencc-by-4.0Feb 2020View details →

Data files used to evaluate the performance of endomaker

Data linked to the publication "Technical note: endomaker, a new algorithm for fully automatic extraction of cranial endocasts and the calculation of their volumes"

opencdla-sharing-1.0Oct 2024View details →

Molecular diffusion enhanced performance evaluation of metal-organic frameworks for carbon dixoide capture

This data set contains the process-level performance ranking of 982 metal-organic frameworks (MOF) which were down-selected from 10,143 structures contained in the puplic CoRE MOF 2019 data set. To rankorder MOFs for application in post-combustion carbon dioxide capture, we have used a computational workflow that combines active-learning based structure selection, molecular-level modeling, and process-level optimization. A detailed description of the repository content is provided in the README file which is included in the zip archive “Diffusion-MOF-Screening.zip”.

dryad24/100

Single-arm, open-label, multicenter first in human study to evaluate the safety and performance of Dura Sealant Patch in reducing CSF leakage following elective cranial surgery: The ENCASE trial

Objective: The Dural Sealant Patch (DSP) is designed for watertight dural closure after cranial surgery. The goal of this study is to assess, for the first time, safety and performance of the DSP as a means of reducing CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure. Design: First in human, open-label, single-arm, multicenter study with 360 days (12 months) follow up. Setting: Three large tertiary reference neurosurgical centers, 2 in the Netherlands and 1 in Switzerland. Participants: Forty patients undergoing elective cranial neurosurgical procedures, stratified into 34 supra- and 6 infratentorial trepanations. Intervention: Each patient received one DSP after cranial surgery and closure of the dura mater with sutures. Outcome measures: Primary composite endpoint was occurrence of one of the following events: postoperative percutaneous CSF leakage, intraoperative leakage at 20 cm H2O positive end-expiratory pressure or postoperative wound infection. Overall success was defined as achieving the primary endpoint in no more than 2 patients. Secondary endpoints were device related serious adverse events (SAEs) or adverse events (AEs), pseudomeningocele and thickness of dura + DSP. Additional endpoints were reoperation in 30 days and user satisfaction. Results: No patients met the primary endpoint. No device related (S)AEs were observed. There were two incidences of self-limiting pseudomeningocele as confirmed on MRI. Thickness of dura and DSP were (mean +/- SD) 3.5 mm +/- 2.0 at day 7 and 2.1 mm +/- 1.2 at day 90. No patients were re-operated within 30 days. Users reported a satisfactory design and intuitive application. Conclusions: DSP, later officially named Liqoseal, is a safe and potentially efficacious device for reducing CSF leakage after intracranial surgery, with favorable clinical handling characteristics. A randomized controlled trial is needed to assess Liqoseal efficacy against the best current practice for reducing postoperative CSF leakage. Strengths and limitations <ul> <li>The trial studies a device to prevent postoperative cerebrospinal fluid (CSF) leakage, which is one of the most common neurosurgical complications.</li> <li>The study protocol was performed in multiple centers, registered, pre-published and strictly followed.</li> <li>The composite endpoint of the trial reduced the number of inclusions needed.</li> <li>The study did not involve a comparison to current clinical standard and has a potential selection bias, so generalization of results with regard to DSP efficacy needs to be cautiously undertaken.</li> </ul>

opencc-zeroJul 2021View details →

opencc-by-4.0Jun 2023View details →

Source Data for "Comparative evaluation of synthetic cytokines for enhancing production and performance of NK92 cell-based therapies"

These data are source material for the manuscript, Comparative evaluation of synthetic cytokines for enhancing production and performance of NK92 cell-based therapies, published in GEN Biotechnology (in press). These data include flow cytometry files, raw images, and data used to generate figures.

opencc-by-nc-sa-4.0Sep 2023View details →

Expert and Novice Evaluations of Piano Performances

This dataset was collected to compare performance assessment criteria used by experts and novices. Beyond the 83 amateur piano performance audio recordings (in the WAV format) and the 803 evaluation entries of these performances, the dataset also contains each player's self-identified skill level, seven digital scores (in the MusicXML format), and 83 audio-to-score alignment files indicating the starting time in the audio of each musical note in the scores. The included CSV file contains 83 rows, each row representing one piano performance. Each performance was evaluated by four professional piano instructors, and by five or six randomly chosen peer players (one of whom could be the performer him/herself as the player information was never shared). The columns in the CSV file specify each performance’s score name, its player (identified by a number from 1 to 21), as well as the numerical and textual evaluations from the four instructors and from the peer players. More information can be found on the project website: https://facultystaff.richmond.edu/~yjiang3/papers/ismir23/.

Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)

ClinicalTrials.gov study NCT04437082. IPD Sharing: NO. Countries: 1. Publications: 0.

Evaluation of Performances and Safety of the Medical Device Blueback® Physio for Patients With Chronic Low Back Pain

ClinicalTrials.gov study NCT04592094. IPD Sharing: NO. Countries: 1. Publications: 0.

Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform

ClinicalTrials.gov study NCT00247299. IPD Sharing: Not stated. Countries: 1. Publications: 0.

A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).

ClinicalTrials.gov study NCT02358629. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens Wearers

ClinicalTrials.gov study NCT01494545. IPD Sharing: Not stated. Countries: 0. Publications: 0.

The Sentio System: Post-market Evaluation of Safety and Performance in Adolescents

ClinicalTrials.gov study NCT06844071. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Post Marketing Clinical Evaluation Assessing the Visual Performance of Hanita Lenses "Intensity SL" Intraocular Lens

ClinicalTrials.gov study NCT06075459. IPD Sharing: NO. Countries: 1. Publications: 0.

Evaluation of Clinical Performance and IVD Test of LifeOS Digital PCR Liquid Biopsy Kits for EGFR T790M Mutation

ClinicalTrials.gov study NCT06573073. IPD Sharing: NO. Countries: 1. Publications: 0.

Performance Evaluation of the Micromedic CD24 in Vitro Diagnostic Assay

ClinicalTrials.gov study NCT01214512. IPD Sharing: Not stated. Countries: 1. Publications: 0.

A Study to Evaluate the Performance of a Diagnostic Test in ALS

ClinicalTrials.gov study NCT02759913. IPD Sharing: NO. Countries: 1. Publications: 0.